These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 16312410

  • 1. Antibiotic resistance, beta-lactamase activity, and plasmid content in strains of Haemophilus and Branhamella isolated from children.
    Facinelli B, Montanari MP, Ratsch I, Brescia A, Oggiano N, Giorgi PL, Varaldo PE.
    J Chemother; 1989 Jul; 1(4 Suppl):301. PubMed ID: 16312410
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
    Esel D, Ay-Altintop Y, Yagmur G, Gokahmetoglu S, Sumerkan B.
    Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
    [Abstract] [Full Text] [Related]

  • 3. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
    Querol-Ribelles JM, Molina J, Naberan K, Esteban E, Herreras A, Garcia-de-Lomas J.
    Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
    [Abstract] [Full Text] [Related]

  • 4. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ, Woods C, Stout G, Martin B, Selvarangan R.
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
    Schmitz FJ, Boos M, Mayer S, Verhoef J, Milatovic D, Fluit AC.
    J Antimicrob Chemother; 2002 Jan; 49(1):220-3. PubMed ID: 11751796
    [No Abstract] [Full Text] [Related]

  • 6. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K, Jakoniuk P, Sacha PT, Zalewska M, Wieczorek P.
    Med Dosw Mikrobiol; 2004 Jan; 56(3):231-7. PubMed ID: 15773499
    [Abstract] [Full Text] [Related]

  • 7. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
    Köseoğlu O, Ergin A, Gürkan Aydin N, Hasçelik G.
    Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of ampicillin/sulbactam and other antibiotics against clinical isolates of Haemophilus sp. and Branhamella catarrhalis.
    Stefani S, Russo G, Pellegrino MB, Mezzatesta ML, Cocuzza C, Nicoletti G.
    J Chemother; 1990 Feb; 2(1):26-30. PubMed ID: 2110245
    [Abstract] [Full Text] [Related]

  • 9. The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children.
    Suzuki K, Baba S, Inagaki M, Kobayashi T.
    Auris Nasus Larynx; 1988 Feb; 15(2):105-11. PubMed ID: 3144965
    [Abstract] [Full Text] [Related]

  • 10. Antibiogram pattern of Moraxella catarrhalis isolates in acute exacerbation chronic obstructive pulmonary disease.
    Christol TJ, Shankar EM, Rao UA.
    Chemotherapy; 2011 Feb; 57(1):94-6. PubMed ID: 21346354
    [No Abstract] [Full Text] [Related]

  • 11. High prevalence and molecular analysis of macrolide-nonsusceptible Moraxella catarrhalis isolated from nasopharynx of healthy children in China.
    Liu Y, Zhao C, Zhang F, Chen H, Chen M, Wang H.
    Microb Drug Resist; 2012 Aug; 18(4):417-26. PubMed ID: 22394083
    [Abstract] [Full Text] [Related]

  • 12. Antimicrobial activity of cefditoren tested against contemporary (2004-2006) isolates of Haemophilus influenzae and Moraxella catarrhalis responsible for community-acquired respiratory tract infections in the United States.
    Biedenbach DJ, Jones RN, Fritsche TR.
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):240-4. PubMed ID: 18353594
    [Abstract] [Full Text] [Related]

  • 13. [Nosopharyngeal microflora in ambulatory treated children and adults with upper respiratory tract infections].
    Zientara M, Rudy M, Nowakowska M, Martirosian G.
    Med Dosw Mikrobiol; 2006 Jun; 58(3):239-45. PubMed ID: 17340999
    [Abstract] [Full Text] [Related]

  • 14. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE, Slocombe B, White AR.
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract] [Full Text] [Related]

  • 15. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
    Ahmad N, Cheong YM, Tahir HM.
    Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
    [Abstract] [Full Text] [Related]

  • 16. Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey.
    Gonullu N, Catal F, Kucukbasmaci O, Ozdemir S, Torun MM, Berkiten R.
    Chemotherapy; 2009 Jun; 55(3):161-7. PubMed ID: 19390189
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis isolates in eight Central, East and Baltic European countries in 2005-06: results of the Cefditoren Surveillance Study.
    Gracia M, Díaz C, Coronel P, Gimeno M, García-Rodas R, del Prado G, Huelves L, Ruiz V, Naves PL, Ponte MC, Granizo JJ, Soriano F.
    J Antimicrob Chemother; 2008 May; 61(5):1180-1. PubMed ID: 18316820
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.
    Köseoglu O, Ergin A, Hascelik G.
    Scand J Infect Dis; 2004 May; 36(6-7):431-4. PubMed ID: 15307563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.